BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2784586)

  • 1. Endotoxin enhancement of toxic shock syndrome toxin 1-induced secretion of interleukin 1 by murine macrophages.
    Beezhold DH; Best GK; Bonventre PF; Thompson M
    Rev Infect Dis; 1989; 11 Suppl 1():S289-93. PubMed ID: 2784586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages.
    Beezhold DH; Best GK; Bonventre PF; Thompson M
    Infect Immun; 1987 Dec; 55(12):2865-9. PubMed ID: 3500130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.
    Uchiyama T; Kamagata Y; Yan XJ; Kohno M; Yoshioka M; Fujikawa H; Igarashi H; Okubo M; Awano F; Saito-Taki T
    Clin Exp Immunol; 1987 Jun; 68(3):638-47. PubMed ID: 3498581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of murine hemopoietic growth factors by toxic shock syndrome toxin-1.
    Galelli A; Anderson S; Charlot B; Alouf JE
    J Immunol; 1989 Apr; 142(8):2855-63. PubMed ID: 2784816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
    Micusan VV; Mercier G; Bhatti AR; Reiser RF; Bergdoll MS; Oth D
    Immunology; 1986 Jun; 58(2):203-8. PubMed ID: 3486824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1.
    Parsonnet J; Gillis ZA
    J Infect Dis; 1988 Nov; 158(5):1026-33. PubMed ID: 3263447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin.
    Uchiyama T; Kamagata Y; Wakai M; Yoshioka M; Fujikawa H; Igarashi H
    Microbiol Immunol; 1986; 30(5):469-83. PubMed ID: 3489157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.
    Parsonnet J; Hickman RK; Eardley DD; Pier GB
    J Infect Dis; 1985 Mar; 151(3):514-22. PubMed ID: 3871826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
    Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
    Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic shock syndrome toxin 1 enhances synthesis of endotoxin-induced tumor necrosis factor in mice.
    Henne E; Campbell WH; Carlson E
    Infect Immun; 1991 Sep; 59(9):2929-33. PubMed ID: 1879919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes.
    See RH; Kum WW; Chang AH; Goh SH; Chow AW
    Infect Immun; 1992 Jul; 60(7):2612-8. PubMed ID: 1612731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells.
    Chatila T; Wood N; Parsonnet J; Geha RS
    J Immunol; 1988 Feb; 140(4):1250-5. PubMed ID: 2830336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice.
    Dinges MM; Schlievert PM
    Infect Immun; 2001 Mar; 69(3):1256-64. PubMed ID: 11179286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of metallothionein by superantigenic bacterial exotoxin: probable involvement of the immune system.
    Choudhuri S; McKim JM; Klaassen CD
    Biochim Biophys Acta; 1994 Jan; 1225(2):171-9. PubMed ID: 8280785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1.
    Keane WF; Gekker G; Schlievert PM; Peterson PK
    Am J Pathol; 1986 Jan; 122(1):169-76. PubMed ID: 3079956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.
    Narita K; Hu DL; Asano K; Nakane A
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of selective anergy by toxic shock syndrome toxin-1 in CD8+ T cells.
    Zhao YX; Holmdahl R; Tarkowski A
    Immunology; 1997 Oct; 92(2):188-93. PubMed ID: 9415025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.
    Bonventre PF; Thompson MR; Adinolfi LE; Gillis ZA; Parsonnet J
    Infect Immun; 1988 Jan; 56(1):135-41. PubMed ID: 3257201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice.
    Radons J; Burkart V; Kolb H
    Diabetes; 1997 Mar; 46(3):379-85. PubMed ID: 9032092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.